What connects splicing of transfer RNA precursor molecules with pontocerebellar hypoplasia?. (14th December 2022)

• Record Type: Journal Article
• Authors: Sekulovski, Samoil; Trowitzsch, Simon
• Is Part Of: BioEssays. Volume 45:Number 2(2023)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2022-12-14
• Subjects: animal models -- disease modeling -- endonuclease -- neurodegenerative disorders -- patient‐derived models -- RNA processing; Molecular biology -- Periodicals; Cytology -- Periodicals; Developmental biology -- Periodicals; 572.8
• DOI: 10.1002/bies.202200130
• Languages: English
• ISSNs: 0265-9247

Abstract

Abstract: Transfer RNAs (tRNAs) represent the most abundant class of RNA molecules in the cell and are key players during protein synthesis and cellular homeostasis. Aberrations in the extensive tRNA biogenesis pathways lead to severe neurological disorders in humans. Mutations in the tRNA splicing endonuclease (TSEN) and its associated RNA kinase cleavage factor polyribonucleotide kinase subunit 1 (CLP1) cause pontocerebellar hypoplasia (PCH), a heterogeneous group of neurodegenerative disorders, that manifest as underdevelopment of specific brain regions typically accompanied by microcephaly, profound motor impairments, and child mortality. Recently, we demonstrated that mutations leading to specific PCH subtypes destabilize TSEN in vitro and cause imbalances of immature to mature tRNA ratios in patient‐derived cells. However, how tRNA processing defects translate to disease on a systems level has not been understood. Recent findings suggested that other cellular processes may be affected by mutations in TSEN/CLP1 and obscure the molecular mechanisms of PCH emergence. Here, we review PCH disease models linked to the TSEN/CLP1 machinery and discuss future directions to study neuropathogenesis. Abstract : Impaired transfer RNA (tRNA) splicing has been postulated as main driver for the orphan neurodegenerative disorder pontocerebellar hypoplasia (PCH). Recent evidence from animal model systems suggested that messenger RNA (mRNA) processing defects are also associated with PCH. To comprehensively understand the molecular mechanisms that lead to PCH, a multidisciplinary approach is needed.